BeiGene, Ltd. (HKG: 6160)
Hong Kong
· Delayed Price · Currency is HKD
138.20
+4.30 (3.21%)
Jan 28, 2025, 12:08 PM HKT
BeiGene Employees
BeiGene had 10,600 employees as of December 31, 2023. The number of employees increased by 1,600 or 17.78% compared to the previous year.
Employees
10,600
Change (1Y)
1,600
Growth (1Y)
17.78%
Revenue / Employee
2.46M HKD
Profits / Employee
-626.26K HKD
Market Cap
188.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Hansoh Pharmaceutical Group Company | 9,123 |
JD Health International | 3,118 |
WuXi Biologics | 12,740 |
Sinopharm Group | 115,959 |
Alibaba Health Information Technology | 1,435 |
Akeso | 2,778 |
Innovent Biologics | 4,872 |
CSPC Pharmaceutical Group | 23,500 |
BeiGene News
- 15 days ago - BeiGene Stock Meets 80-Plus RS Rating Benchmark - Investor's Business Daily
- 24 days ago - BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe - Business Wire
- 4 weeks ago - BeiGene (BGNE) Stock Rises on FDA Approval for Cancer Treatment - GuruFocus
- 4 weeks ago - BeiGene wins FDA nod for Tevimbra in gastric cancer - Seeking Alpha
- 4 weeks ago - TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy - Business Wire
- 5 weeks ago - BeiGene (BGNE) Announces Ticker Change to ONC Effective January 2025 - GuruFocus
- 5 weeks ago - BeiGene Ltd (BGNE) Announces Ticker Symbol Change to "ONC" in 2025 - GuruFocus
- 5 weeks ago - BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire